The sensitivity and specificity of Brucella agglutination tests

被引:87
作者
Mert, A [1 ]
Ozaras, R [1 ]
Tabak, F [1 ]
Bilir, M [1 ]
Yilmaz, M [1 ]
Kurt, C [1 ]
Ongoren, S [1 ]
Tanriverdi, M [1 ]
Ozturk, R [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey
关键词
Brucella agglutination test; sensitivity; specificity;
D O I
10.1016/S0732-8893(03)00081-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Brucellosis is a systemic infectious disease caused by Gram-negative bacilli, the genus Brucella, and clinical features are diverse. Therefore, several infectious and non-infectious diseases are considered in its differential diagnosis. In this study, we aimed to determine the positivity rate of Brucella agglutination tests in the culture-positive brucellosis and in diseases mimicking brucellosis clinically. Thirty patients with culture-positive brucellosis, and 280 patients with the diseases mimicking brucellosis clinically (20 with miliary tuberculosis, 33 with malaria, 20 with typhoid fever, 20 with adult-onset Still's disease, 47 with systemic lupus erythematosus, 50 with rheumatoid arthritis, 27 with sarcoidosis, and 63 with active lyrnphoma) were included in the study. Brucella agglutination tests (Rose-Bengal and Wright) were studied in serum samples of these 310 patients. Both Rose-Bengal and Wright tests (the latter in a titer of 1/160 or higher) were positive in all patients with brucellosis. For the other diseases. the test was slightly positive (1/40) in one patient with malaria and another with non-Hodgkin's lymphoma, and weakly positive (1/20) in a patient with typhoid fever. It remained negative in the remaining. In conclusion, agglutination tests currently used in the diagnosis of brucellosis are very sensitive and specific. Brucellosis can be effectively excluded from the diseases having similar clinical features by the use of agglutination tests. paired right arrows 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:241 / 243
页数:3
相关论文
共 12 条
[1]   QUINOLONES IN TREATMENT OF HUMAN BRUCELLOSIS - COMPARATIVE TRIAL OF OFLOXACIN-RIFAMPIN VERSUS DOXYCYCLINE-RIFAMPIN [J].
AKOVA, M ;
UZUN, O ;
AKALIN, HE ;
HAYRAN, M ;
UNAL, S ;
GUR, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1831-1834
[2]  
ALTWEGG M, 1985, ZBL BAKT-INT J MED M, V260, P65
[3]  
Cetin ET, 1990, DOGA T J MED SCI, V14, P324
[4]   Complications associated with Brucella melitensis infection: A study of 530 cases [J].
Colmenero, JD ;
Reguera, JM ;
Martos, F ;
SanchezdeMora, D ;
Delgado, M ;
Causse, M ;
MartinFarfan, A ;
Juarez, C .
MEDICINE, 1996, 75 (04) :195-211
[5]  
GOKTAS P, 1991, TURK MIKROBIOL CEM D, V21, P199
[6]   AN EVALUATION OF DIAGNOSTIC METHODS FOR BRUCELLOSIS - THE VALUE OF BONE-MARROW CULTURE [J].
GOTUZZO, E ;
CARRILLO, C ;
GUERRA, J ;
LLOSA, L .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (01) :122-125
[7]   Comparison of the Brucella Standard Agglutination Test with the ELISA IgG and IgM in patients with Brucella bacteremia [J].
Memish, ZA ;
Almuneef, M ;
Mah, MW ;
Qassem, LA ;
Osoba, AO .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 44 (02) :129-132
[8]  
Moyer Nelson P., 1995, P549
[9]   Diagnosis of brucellosis by using blood cultures [J].
Ruiz, J ;
Lorente, I ;
Perez, J ;
Simarro, E ;
MartinezCampos, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (09) :2417-2418
[10]   Detection of Brucellae in blood cultures [J].
Yagupsky, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (11) :3437-3442